The UK government has mapped out how it plans to move away from animal testing in medicine and safety research — a shift that hinges on newer lab methods using human cells and artificial tissue instead of live animals.
By the end of 2025, scientists will stop using rabbits for a major safety test called the pyrogen test, replacing it with a procedure using human immune cells. All tests that currently use animals to check for dangerous germs in medicines will move to cell and gene technologies. That's the immediate target. The longer view is more ambitious: the government aims to cut the use of dogs and non-human primates in drug testing by at least 35% by 2030.
The shift isn't just about replacing one test with another. Over the next decade, the government plans to accelerate adoption of "organ-on-a-chip" devices — lab-grown tissue systems that mimic how human organs actually work — alongside AI-powered analysis. A new Centre for the Validation of Alternative Methods will be created to prove these alternatives are reliable enough for widespread use. The government is backing this with £30 million for a research hub and additional grants for teams developing non-animal methods.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News DetoxThe Complexity Problem
Not everyone is convinced this can work completely. Prof. Frances Balkwill at Queen Mary University notes that non-animal methods "will never replace the complexity that we can see when we have a tumour growing in a whole organism, such as a mouse." Some cancer research and brain studies are genuinely difficult to model outside a living system. Prof. Robin Lovell-Badge has flagged concerns that aggressive timelines could harm science in these areas.
The RSPCA has welcomed the plan as "a significant step forward" while pressing the government to actually deliver — a reminder that announcements and implementation are different things.
What makes this moment different is the convergence: human cell cultures have become more sophisticated, AI can process vastly more data, and the political will exists to fund the transition. The 2025 deadline for the pyrogen test is a concrete milestone. Whether the 35% reduction by 2030 holds depends on how quickly these alternatives can be validated and adopted across the research sector.
